ExodusPoint Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-27,101
| Closed | -$388K | – | 2051 |
|
2024
Q3 | $388K | Buy |
27,101
+3,203
| +13% | +$45.9K | ﹤0.01% | 1194 |
|
2024
Q2 | $387K | Buy |
23,898
+8,066
| +51% | +$131K | ﹤0.01% | 1139 |
|
2024
Q1 | $1.6M | Sell |
15,832
-374
| -2% | -$37.8K | 0.01% | 689 |
|
2023
Q4 | $382K | Sell |
16,206
-3,270
| -17% | -$77.1K | ﹤0.01% | 1038 |
|
2023
Q3 | $393K | Sell |
19,476
-1,848
| -9% | -$37.3K | ﹤0.01% | 1278 |
|
2023
Q2 | $554K | Buy |
21,324
+1,737
| +9% | +$45.1K | ﹤0.01% | 1231 |
|
2023
Q1 | $407K | Buy |
19,587
+7,037
| +56% | +$146K | ﹤0.01% | 1297 |
|
2022
Q4 | $256K | Buy |
12,550
+3,935
| +46% | +$80.3K | ﹤0.01% | 1348 |
|
2022
Q3 | $238K | Buy |
8,615
+3,610
| +72% | +$99.7K | ﹤0.01% | 1558 |
|
2022
Q2 | $132K | Buy |
+5,005
| New | +$132K | ﹤0.01% | 1664 |
|
2021
Q2 | – | Sell |
-892
| Closed | -$344K | – | 2826 |
|
2021
Q1 | $344K | Buy |
+892
| New | +$344K | 0.01% | 1533 |
|